The present study found that BZYQF significantly improved the symptoms of polyuria, polyphagia, polydipsia, and weight loss in T2DM rats, reduced the levels of FBG, TC, and TG, and increased insulin levels and HOMA-β in the serum of T2DM rats. The gene discussed is INS; the disease is Polyphagia.